Pennsylvania · 2025-2026 Regular Session · Bill

SB 866: An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for schedules of controlled substances and for secure storage of xylazine; and adding provisions relating to medetomidine.

Passed one chamber Last action June 10, 2026: Referred to Judiciary

Plain-language summary

SB 866 is a bill introduced in the Pennsylvania Senate on July 24, 2025. According to its official title, it concerns: An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for schedules of controlled substances and for secure storage of xylazine; and adding provisions relating to medetomidine. Primary sponsor: Michele Brooks (Republican). It lists 3 additional sponsors. Most recent recorded action (June 10, 2026): Referred to Judiciary.

Sponsors

Primary sponsor: Michele Brooks (Republican). 3 co-sponsors.